Purpose: Sepsis is a devastating condition with considerable mortality. The causes of long-term mortality are poorly understood. To test the hypothesis that patients with sepsis are more susceptible to recurrent infections and death due to infectious complications, we investigated the outcomes of patients who survived sepsis, with regard to the incidence of recurrent infections and mortality. Materials and Methods: A retrospective study of the patients admitted to the intensive care unit (ICU) for sepsis from 2001 to 2002 who achieved 30-day survival (sepsis survivors [SSs], N ¼ 78) and a control group of patients admitted to the ICU for noninfectious conditions with a similar severity of illness (N ¼ 50) was performed. The primary end point was the number of recurrent infections in the first year posthospitalization. Results: The SSs group had higher rates of infections following hospital discharge compared to controls. Using a multivariable model, having survived sepsis was the strongest predictor of the development of subsequent infections (rate ratio [RR]: 2.83, P ¼ .0006), the need for rehospitalization for infection in the year after the initial hospitalization (RR: 3.78, P ¼ .0009), and postdischarge mortality (hazard ratio ¼ 3.61, P ¼ .003). Conclusions: Critically ill patients who survive sepsis have an increased risk of recurrent infections in the year following their septic episode that is associated with increased mortality.
Introduction
Sepsis is a devastating condition that remains a major cause of morbidity and mortality in the United States and worldwide. 1, 2 With advances in supportive care, the in-hospital mortality rate has improved over time which has resulted in increasing number of sepsis survivors. 2 Unfortunately, sepsis survivors have been found to have a number of poor long-term outcomes including impaired quality of life and mortality that extends beyond the standard 28-day in-hospital mortality end point. 3 A large cohort study by Quartin and colleagues found that survivors of sepsis had an increased risk of death that persisted for up to 5 years following the initial septic event, even after accounting for their underlying medical comorbidities. 4 The mechanism of this increased long-term mortality following sepsis remains unclear.
In the past decade, the pathophysiology of the sepsis syndrome has shifted from a paradigm of uncontrolled inflammation to one of ''sepsis-induced immunosuppression,'' a state of immune dysregulation in which anti-inflammatory immunologic events develop concurrently or subsequently throughout the course of sepsis. 5 A recently published postmortem study found evidence of biochemical, flow cytometric, and immunohistochemical findings consistent with immunosuppression in patients who died in the intensive care unit (ICU) following sepsis compared to patients who died of nonsepsis etiologies. 6 Furthermore, both the literature and anecdotal experience suggest that many patients survive sepsis only to succumb to other infections, often after a protracted hospital course or during a subsequent admission to the hospital. 7, 8 Sepsis-induced immunosuppression has been postulated to contribute to sepsis-related mortality because of the inability to fight secondary infections in the postseptic period, 9 though the true clinical impact of this remains unclear. To our knowledge, no studies have examined the incidence and types of infections in patients who survive sepsis. We therefore performed a retrospective cohort study to determine whether critically ill patients who survive an episode of sepsis (sepsis survivors [SSs] ) are more susceptible to recurrent infections and death due to infectious complications when compared to patients without sepsis with a similar severity of critical illness.
Methods Setting
The West Los Angeles Veteran Affairs (VA) Healthcare Center is a tertiary medical center with a level 1 ICU, a VA designation that includes a complex patient population and a full-time intensivist. Approximately 800 patients are admitted annually. Since 1990, a computerized database designated as the patient registry has been kept for all ICU admissions at this facility. In addition to standard patient demographics, the registry contains prospectively collected data on admission and discharge diagnoses, admission Acute Physiology and Chronic Health Evaluation (APACHE) II scores, and discharge locations. The VA also has an extensive electronic medical record (EMR; Computerized Patient Record System current version 1.0.27) with comprehensive data available since 1999.
Inclusion Criteria
We reviewed patient registry data between January 1, 2001, and December 31, 2002 and identified all patients admitted to the ICU with a diagnosis of sepsis that achieved 30-day survival (N ¼ 78). A separate contemporaneous control group of patients admitted to the ICU with noninfectious diagnoses and that achieved 30-day survival were matched using admission APACHE II scores within 2 points of the first 50 cases (N ¼ 50). Controls were unable to be matched for all 78 cases secondary to the lack of adequate numbers of control participants with sufficiently elevated APACHE II scores that were within 2 points of the case participants.
Exclusion Criteria
Patients were excluded if they had the following conditions or treatments: solid organ or bone marrow transplantation, AIDS, hematologic malignancies, recent chemotherapy within 30 days, chronic corticosteroid use (equivalent of >10 mg/d of prednisone), or chronic immunosuppressive medications.
Criteria for Infection
Infections in the ICU were identified using chart review and based on criteria from the 2003 International Sepsis Forum Consensus Conference for the 6 most common infections such as pneumonia, bloodstream infections, intravascular catheterrelated sepsis, intraabdominal infections, urosepsis, and surgical wound infections. 10 To be considered an infection, ''microbiologically confirmed'' and ''probable'' criteria for infection had to be fulfilled. For other infections not included in the above categories and subsequent infections not in the ICU, infections were identified based on documentation by the treating physician of an infection as well as evidence of an intervention as a result of the infection (ie, antimicrobial therapy or discontinuation of a catheter). Sites of infection and microorganisms identified were also collected for every subsequent infection in the 1-year period after the initial hospitalization. Positive Candida cultures were not counted if isolated from respiratory samples or from the urine, in the absence of evidence of invasive disease or bloodstream infection.
End points
Participants' records were reviewed and the data was abstracted onto an Excel worksheet using a standardized case report form. Records were reviewed during their index ICU admission and for the ensuing year using the VA EMR. The primary end point was the number of recurrent infections in the first year posthospitalization inclusive of both inpatient and outpatient documented infections. Secondary end points were the number of rehospitalizations for infection and survival in the year posthospitalization.
Institutional Review Board
The study was approved by the VA Greater Los Angeles Healthcare System Institutional Review Board (PCC 2006-060932). The committee waived the need for informed consent since it involved analysis of existing data and posed minimal patient risk.
Statistical Analysis
Statistical analysis was performed using SAS software (version 9.2, SAS Institute Inc, Cary, North Carolina) and figures were created using GraphPad Prism (version 5.0, GraphPad Software, San Diego, California). Baseline variables were compared using Fisher exact test. Quantitative variables were compared using the independent 2-sample t test or Wilcoxon rank-sum test when appropriate. Univariable and multivariable Cox proportional hazards models of mortality were constructed along with survival plots using the Kaplan-Meier method.
Mean cumulative function plots for the recurrent events of postdischarge infections and rehospitalizations for infection were created using the method described by Nelson. 11 Univariable and multivariable proportional rates/means models (also known as independent-incremental models) were created for the respective recurrent events. [12] [13] [14] This is a semiparametric method analogous to Cox proportional hazards models for survival in the context of recurring longitudinal outcomes data that represent a count process such as infections. Standard errors for the resulting model parameters were calculated using robust sandwich estimates for the covariance matrices, aggregating the score residuals per participant. First-order interaction terms were tested in final multivariable models and none met statistical significance. Final models were validated by bootstrapping (1000 samples and resampling participants with replacement).
Variable selection for multivariable models was performed by backward selection based on Wald criteria.
Results

Baseline Patient Characteristics
We compared the baseline characteristics for critically ill patients with sepsis (SSs) and patients with critical illness without sepsis, who survived for 30 days after being admitted to the ICU (Table 1) . Patients who were known to be immunocompromised at baseline, including patients with neutropenia, organ transplant, or active malignancy or taking immunosuppressive medications, were excluded so as to minimize the contribution of these conditions to secondary infections. Sepsis survivors were an older population (mean age 70 vs 64 years) and more often admitted from a nursing home. Survivors of sepsis were also more likely to have an indwelling catheter or a history of malignancy (predominantly prostate and skin), but other chronic comorbidities were similar. A total of 25 patients with sepsis had 14 urinary catheters, 12 gastrostomy tubes, 2 tracheostomy tubes, and 2 dialysis catheters. In total, 63% of the SSs had an infection in the year prior to admission compared to 26% of the controls. The mean APACHE II score obtained at admission was well-matched at 21 points in both groups (SD 7 for SSs, 6 for controls) demonstrating comparable severity of critical illness. Sepsis survivors had an increased use of mechanical ventilation and vasopressor therapy. The most common admission diagnoses in the control group were gastrointestinal bleed and cardiac conditions, including congestive heart failure, myocardial infarction, arrhythmias, and hypertensive emergency.
In-Hospital Outcomes
The SSs had longer ICU and hospital lengths of stay when compared to controls. The median length of ICU stay for SSs was 6 days compared to 3 days in the controls (P < .0001), and the median length of hospital stay was 20 days compared to 7 days in the SSs and control groups, respectively (P < .0001). In-hospital mortality for the 30-day survivors of sepsis was overall low at 5%. No control patients surviving 30 days subsequently died in the hospital.
Subsequent Infections in the Year Posthospitalization
Given that the majority of participants survived till hospital discharge, we examined long-term outcomes among the SSs and non-SSs of critical illness (controls). The SS group had markedly higher rates of new infections following discharge compared to controls (Figure 1) , with differences persisting out to 1 year. Over the first year, patients with sepsis developed postdischarge infections at an unadjusted rate ratio (RR) of 5.68 (95% confidence interval 3.21-10.03, P < .00001) compared to controls ( Table 2) . Overall, there were significant differences in the percentage of patients who had a postdischarge subsequent infection (63% of SSs compared to 30% of controls [P < .001]). We then analyzed the predictive factors for postdischarge infections. Although being a survivor of sepsis was the most significant predictor of subsequent infections in univariable models, other significant predictors included being in the highest quartile of age (78-98 years), admission from a nursing home, a prolonged hospital stay (defined as 13 days which was the median length of stay [LOS]), a neurological comorbidity, the presence of an indwelling catheter/foreign body, an infection in the year prior to hospitalization, and decreased albumin ( Table 2) . A history of substance abuse was a negative predictor of postdischarge infections, which we speculated could be attributable to participants with drug use being younger than other patients.
Risk Factors for Hospital Readmission for Infection
We next examined the risk of hospital readmission specifically for infection among the SSs. The SSs group was more likely to be readmitted with infection during the first year ( Figure 2) . The mean number of rehospitalizations for infections per patient-year was 1.45 for SSs and 0.18 for controls. Among candidate predictors, the initial presence of sepsis was the strongest predictor of rehospitalization for infection with an unadjusted RR of 8.06 (P < .0001), although other variables, including advanced age, admission from nursing home, prolonged hospital LOS, the presence of a catheter/ indwelling foreign body, prior infection in the past year, and low albumin were also significant univariate predictors ( Table 2 ). Malignancy and diabetes were not significant predictors, while substance abuse was negatively associated.
Covariate Analysis for Recurrent Postdischarge Infections and Hospitalization
We next adjusted for the significant covariates identified in the univariate model to determine the relative impact of sepsis in the development of postdischarge infections. We found that having survived an episode of sepsis still remained the most significant factor associated with developing subsequent postdischarge infections (RR ¼ 2.83, P ¼ .0006) although prolonged hospitalization, advanced age, and admission from a nursing facility remained significant predictors ( Table 3 , left panel). After adjusting for other significant factors, we found that the presence of sepsis remained the strongest predictor of readmission for an infectious cause, with an adjusted RR of 3.78 (P < .009; Table 3 , right panel). Prolonged hospitalization, advanced age, and the presence of an indwelling catheter/ foreign body were also significant predictors.
Sites of Infection and Microorganisms Identified
In addition to analyzing the rates of secondary infections, we also sought to determine whether SSs had a qualitative difference in the types and microbiology of secondary infections. We observed that the type of infection in the SSs group was predominantly pneumonia while the controls mostly had urinary tract infections ( Figure 3A) . The microorganisms identified also differed. The SSs group was more likely to develop infections with opportunistic pathogens such as Pseudomonas aeruginosa and Candida species, whereas no cases of P aeruginosa or Candida species occurred in the controls ( Figure 3B ).
Overall Survival
Finally, we examined long-term survival in both groups and found that the SSs group had a higher subsequent 1-year mortality than controls (52.7% vs 12%; P < .0001; Figure  4 ). Using univariable and multivariable Cox models of mortality, sepsis was found to be the strongest predictor of postdischarge mortality with a hazard ratio (HR) for death of 3.61 ( Table 4 ). Given that vasopressor use was highly associated with sepsis, a separate model that did not take vasopressor use into account led to an even higher HR of 4.36 (P ¼ .0004; Table 5 ).
Causes of death were known for 69% of the SSs and 40% of the controls. For those with a known cause of death, SSs were much more likely to die of an infectious complication than the controls (73% vs 11%; P ¼ .002; data not shown).
Discussion
Sepsis continues to be a significant cause of death worldwide, but an understanding of the mechanisms responsible for mortality remains elusive. Most studies of sepsis have predominantly examined short-term outcomes with the few studies examining long-term outcomes largely focused on mortality and quality of life. 3, [15] [16] [17] Although these studies are crucial to understanding the long-term consequences of sepsis, the reason why patients with sepsis are at an increased long-term risk of death remains poorly understood. To address this question, we compared the characteristics and outcomes of critically ill patients with and without sepsis who survived 30 days after ICU admission and who were matched for severity of illness based upon the initial APACHE II scores. Consistent with earlier studies, 3, 4 we found that patients with sepsis who survive the initial 30 days of critical illness still have significantly higher mortality rates compared to nonseptic survivors of critical illness (Figure 4 ). Not surprisingly, the patients admitted with sepsis were different from critically ill patients without sepsis. Patients with sepsis were, on average, 6 years older than critically ill controls. In addition, they were more likely to have been admitted from a nursing home, to have an underlying malignancy (mostly skin and prostate, as hematologic malignancies were excluded), to have a history of infection in the year prior, and to have an indwelling catheter or foreign body. After admission to the ICU, they were also more likely to require mechanical ventilation and vasopressors. We therefore controlled for these potentially confounding variables through the statistical models as outlined above. Interestingly, after controlling for these confounding variables, we found that patients who survived sepsis remained at increased risk of recurrent infections. Indeed, having survived sepsis remained the strongest predictor of recurrent infections postdischarge, rehospitalizations for infection, and postdischarge mortality after multivariable analysis.
These findings highlight the significant impact of late infectious complications to the long-term outcomes of patients who survive sepsis. At the present time, it is unclear whether patients who acquire sepsis are simply inherently at risk for infectious complications, or whether sepsis imposes additional risk for subsequent infections. However, recent studies suggest that patients with sepsis appear to develop a state of relative immunosuppression secondary to a variety of molecular and cellular mechanisms, including dysfunction of monocytes, dendritic cells, neutrophils, and lymphocytes as outlined in a recent review. 5 This suggests that after a septic episode, hosts may be at increased risk of further infectious complications. Despite this, little data exists regarding the clinical impact of sepsis-induced immunosuppression. Our study attempts to address this issue by comparing long-term outcomes of SSs with survivors of nonsepsis critical illness. Although this study was not designed to prove a causal relationship between sepsis and the development of secondary infections, the results do suggest that the presence of sepsis leads to long-term infectious complications independent of other confounding factors such as advanced age. The increased numbers of infections extended out to 1 year beyond the initial hospitalization, resulting in a higher number of rehospitalizations for infection among survivors of sepsis. Importantly, this association remained after controlling for multiple variables that differed between SSs and controls and having survived a bout of sepsis remained the most significant predictor of subsequent postdischarge infections and readmissions for infectious causes. Furthermore, there was a markedly increased risk of death due to infection among the SSs. Collectively, these results underscore the importance of recurrent infections as a cause of long-term morbidity and mortality in this patient population.
The timing of the recurrent infections also differed in the 2 groups. Almost immediately after hospital discharge, SSs began developing secondary infections (Figure 1 ). The sites of infections and infecting microorganisms also differed between the 2 groups ( Figure 3) with SSs having higher rates of pneumonia and infections with more opportunistic pathogens (eg, P aeruginosa, Candida sp). These findings parallel the findings in animal models of sepsis-induced immunosuppression in which they were found to be susceptible to pneumonias and less virulent nosocomial pathogens such as Pseudomonas sp. 18, 19 Although undoubtedly antimicrobial therapy for the initial septic episode placed selection pressure in favor of these organisms, hosts with otherwise healthy immune responses are not generally at risk for developing invasive disease with these pathogens. Infections caused by Clostridium difficile, which is associated with antibiotic treatment, comprised a small percentage (1.8%) of the postdischarge infections among the SSs. Rather, the patients initially admitted to the ICU for noninfectious reasons ultimately developed infections by more virulent organisms such as Staphylococcus, Streptococcus, and Escherichia coli. However, further investigation is warranted regarding the role that broadspectrum antibiotics may play in altering the host microbiome and colonization patterns, thereby increasing the likelihood of developing certain types of infections in a susceptible host.
There are certain limitations in our study. It is a retrospective study performed in the early 2000s in a VA population largely composed of elderly males; hence, further studies are needed to determine whether the findings are applicable to a more general population. Although there have been changes in supportive care of critically ill patients with sepsis including lung-protective ventilatory strategies (in patients with acute respiratory distress syndrome) and early goal-directed therapy, we would anticipate that these developments would increase the number of long-term survivors of sepsis rather than directly impact the development of infectious complications in participants who have already survived sepsis. Given the study design, we were unable to obtain data on transfusions of blood products, which has been reported to be associated with immunosuppression. 20, 21 However, the most common admitting diagnosis for the nonseptic critically ill controls was gastrointestinal bleeding; therefore, one would anticipate that the nonseptic controls would be more likely to receive blood products than the sepsis group. Also, we chose to match the controls based on initial severity of illness using the admission APACHE II score, which is a well-validated ICU scoring system that includes several baseline patient parameters such as age and history of chronic organ insufficiency. 22 Although there were differences in some baseline characteristics between the sepsis and the nonsepsis groups, none of these were found to increase the risk of repeated infection or hospitalization more than sepsis. Importantly, the 2 groups were similar with regard to other comorbidities that could contribute to infection susceptibility and poor outcomes, including cardiopulmonary, renal, and neurologic disease and diabetes. 23 In addition, the development of renal failure, which has prognostic value in sepsis, 24 was similar between the 2 groups. Nonetheless, without a prospective study examining specific measures of immune function and development of secondary infections, it is difficult to definitively prove the presence of sepsis-induced immunosuppression and if it has a direct causal relationship to secondary infections.
Despite the limitations, we feel that our findings contribute important epidemiologic information about the long-term infectious risks of survivors of sepsis and critical illness. With the abundance of immunologic data supporting the presence of sepsis-induced immunosuppression and the increased long-term mortality in sepsis survivors, there is yet to be a study evaluating the magnitude of this phenomenon in the clinical setting, whether in the short term or long term. This is of extreme importance in this era of critical care medicine as the number of patients who survive sepsis will steadily increase with continued improvements in supportive care. From our and other groups' clinical experience, patients now rarely succumb to their initial bout of sepsis-or even their initial ICU admission-but instead die after a protracted course, often due to a recurrent infection. 7, 8 Our study emphasizes that despite improvements in short-term ICU care, patients who survive sepsis remain at risk for long-term infectious complications. This reinforces the importance of developing diagnostic studies that can aid in assessing immune function in the postseptic period as well as therapies directed towards overcoming the immune dysregulation caused by sepsis.
Conclusion
Sepsis is an independent predictor of recurrent infections, hospitalization for infectious causes, and death in the postseptic period. Prospective studies on SSs are needed with concurrent measurements of immune function parameters to predict and ultimately prevent the growing problem of recurrent infections.
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